These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 7325396)

  • 1. Control and complications of intermittent heparin therapy.
    Norman CS; Provan JL
    Surg Gynecol Obstet; 1977 Sep; 145(3):338-42. PubMed ID: 888052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory control of continuous intravenous heparin therapy with Howel time and activated partial thromboplastin time. A prospective, randomized and blind study.
    Almazan A; Lozano F; Ramos M; Rodriguez-Moran M; Gomez-Alonso A
    Angiology; 1985 Jun; 36(6):363-9. PubMed ID: 4025944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin assays and bleeding complications in treatment of deep venous thrombosis with particular reference to retroperitoneal bleeding.
    Holm HA; Abildgaard U; Kalvenes S
    Thromb Haemost; 1985 Apr; 53(2):278-81. PubMed ID: 4024037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute heparin therapy--standard dose or dosage according to individual sensitivity?].
    Ygge J
    Lakartidningen; 1977 Mar; 74(10):921-4. PubMed ID: 839876
    [No Abstract]   [Full Text] [Related]  

  • 5. An exploratory trial of two dosages of a novel synthetic thrombin inhibitor (napsagatran, Ro 46-6240) compared with unfractionated heparin for treatment of proximal deep-vein thrombosis -- results of the European multicenter ADVENT trial.
    Bounameaux H; Ehringer H; Hulting J; Rasche H; Rapold HJ; Zultak M
    Thromb Haemost; 1997 Sep; 78(3):997-1002. PubMed ID: 9308743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Do the prevention and treatment of deep venous thrombosis have specificity in the cancer patient?].
    Voog E
    Bull Cancer; 1998 Jul; 85(7):618-21. PubMed ID: 9752268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When can the patient with deep venous thrombosis begin to ambulate?
    Aldrich D; Hunt DP
    Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299
    [No Abstract]   [Full Text] [Related]  

  • 8. Heparin assay methods for control of in vivo heparin effects.
    Godal HC
    Thromb Diath Haemorrh; 1975 Feb; 33(1):77-80. PubMed ID: 1091021
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin therapy in venous thromboembolism.
    Hirsh J
    Ann N Y Acad Sci; 1989; 556():378-85. PubMed ID: 2660687
    [No Abstract]   [Full Text] [Related]  

  • 10. [Continuous heparin therapy in deep venous thrombosis and its monitoring with the Howel and thrombin times. Prospective study].
    Lozano Sánchez F; Almazán Enríquez A; Ramos Boyero M; del Villar Galán JL; Gómez Alonso A
    Angiologia; 1981; 33(5):272-82. PubMed ID: 7325396
    [No Abstract]   [Full Text] [Related]  

  • 11. The mechanisms of venous thrombosis. Anticoagulants, aspirin, and heparin.
    O'Brien JR
    Mod Concepts Cardiovasc Dis; 1973 Mar; 42(3):11-5. PubMed ID: 4572065
    [No Abstract]   [Full Text] [Related]  

  • 12. [What is guaranteed in fibrinolytic therapy of deep venous thrombosis?].
    Seifried E
    Internist (Berl); 1990 Nov; 31(11):689-97. PubMed ID: 2289854
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug therapy of deep venous thrombosis].
    Bounameaux H
    Ther Umsch; 1996 Apr; 53(4):272-6. PubMed ID: 8658349
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.